AMEND

The Association for Multiple Endocrine Neoplasia Disorders (AMEND) is a patient group supporting and informing families affected by these rare genetic disorders and their associated endocrine tumours, which include functioning tumours of the adrenal glands, thyroid gland, parathyroid glands, pituitary glad, and endocrine pancreas. Symptoms are varied and can be episodic. The average time to diagnosis for an index patient is 4 years.

VISIT WEBSITE

MIMS Learning Live is a learning series for primary care professionals hosted in a unique in-person or digital format in multiple locations. These events are exclusively for primary healthcare professionals.

This event is made possible by sponsorship from organisations including pharmaceutical companies, med tech companies and service providers who have provided sponsorship towards this independent programme. They have had no editorial input or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the marked sponsored symposia. Sessions delivered with input from these organisations are marked as such on the programme and a list of all sponsors can be found here.

AMEND

Useful links

Our Brands